Labor Dr. Brunner, a German-based medical diagnostic laboratory has adopted the QuantaMatrix dRAST™ (Rapid Antimicrobial Susceptibility Testing) solution for routine clinical use.
The dRAST aims to help clinicians by providing optimal antibiotic treatments for sepsis patients. Its Gram-negative and Gram-positive antibiotic panels deliver fast results for a large variety of sepsis-causing bacteria. The dRAST solution contains various innovative patents and a collection of over 30 million data points on bacteria growth to cut down the diagnostic time from several days to as little as four hours.
“We are sure that the introduction of the dRAST system, which accelerates the routine diagnostic process, will reduce mortality for patients with sepsis and lead to a reduction in consequential damages,” said Prof. Johannes Zander, laboratory medicine specialist at Labor Dr. Brunner.
Part of a constantly evolving rapid AST (Antimicrobial Susceptibility Testing) market, the dRAST solution confirms its presence in Europe and Asia with this additional clinical site – at Labor Dr. Brunner. This latest implementation joins a list of current users that includes Seoul National University Hospital, Chungnam National University Hospital, the Catholic University of Korea Seoul St. Mary’s Hospital, Konkuk University Medical Center, Eunpyeong St Mary’s Hospital, Ehwa Womans University Morkdong Hospital, the Limbach Group in Germany and admed laboratory in Switzerland.
Click on the Request Information below to contact QuantaMatrix directly.
Note: This content has been edited by a rapidmicrobiology staff writer for style and content.
